NCT03554421

Brief Summary

At a tertiary referral centre, 10 patients (4 male and 6 female; mean age 49.8 years) were given neuromodulation via the posterior tibial nerve to the sacral nerve for 30 min on 10 consecutive days. All patients had failed conventional medical treatment. The visual analogue scale (VAS), St. Marks score, Wexner's constipation score, Brief Pain Inventory (BPI - SF), bleeding and mucosal healing were evaluated before treatment, at termination, after 3 months and then yearly during three years.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2014

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 13, 2018

Completed
Last Updated

September 13, 2018

Status Verified

September 1, 2018

Enrollment Period

4 months

First QC Date

May 31, 2018

Last Update Submit

September 12, 2018

Conditions

Keywords

Key Words: Anal Fissure, tibial nerve stimulation

Outcome Measures

Primary Outcomes (1)

  • Rate of wound healing by clinical examination

    Wound healing rate was assessed by visual Clinical examination of the wound taking into consideration the presence or absence of inflammation or epithelialization. The clinical state of the fissure wound was assessed in the scale of : not healed (more than 50% of wound visible), partially healed (more than 50% the healing process was visible but not totally complete) and healed when no sign of the active fissure or inflammation was visible and wound was completely epithilialized.

    3 years

Secondary Outcomes (5)

  • Pain Intensity assessed by Visual Analogue Scale (VAS)

    3 years

  • Pain Inventory as assessed by Brief Pain Inventory (BPI-SF)

    3 years

  • Bleeding of fissure wound as assessed by patient

    3 years

  • Bowel control as assessed by St. Marks Incontinence Score

    1 year

  • Bowel movements assessed by Constipation Score

    1 year

Study Arms (1)

Posterior tibial nerve stimulation

EXPERIMENTAL

Percutaneous tibial nerve stimulation. Stimulation av posterior tibial nerve via neuromodulator for 30 minutes. 10 sessions

Procedure: Percutaneous tibial nerve stimulation

Interventions

A 20Hz electrical current is given via an electrode inserted through the skin over the posterior tibial nerve above the medial malleolus of the foot and the nerve is stimulated until a motor reflex of the big toe is acheived. Treatment is then continued for 30 minutes at this level. The treatment is then repeated for a total of 10 sessions within a 2 week period.

Posterior tibial nerve stimulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Chronic anal fissure for at least 6 months. 2. Above 18 years old. 3. Failed all previous conservative therapy. 4. On high fibre diet.

You may not qualify if:

  • Pregnancy 2. Pacemaker device. 3. Blood thinners - Heparin or Warfarin 4. Neurological disease 5. Inflammatory bowel disease 6. Radiation proctitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Bengt Jeppsson, Professor

    Region Skane

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Treatment known to both investigator and patient
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Only patients with chronic anal fissures treated
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2018

First Posted

June 13, 2018

Study Start

September 30, 2013

Primary Completion

February 11, 2014

Study Completion

March 29, 2017

Last Updated

September 13, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

Nothing planned.